title: Perampanel: a selective AMPA antagonist for treating seizures.
abstract: Perampanel is a selective, noncompetitive AMPA receptor antagonist that has recently been approved for treating localization-related epilepsy. This article reviews the pharmacology, clinical development, efficacy, and safety/tolerability of perampanel.
authors.affiliation: Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD.
authors.forename: Gregory L
authors.initials: GL
authors.lastname: Krauss